Treatment of Human Intraosseous Periodontal Defects Using Recombinant Human Bone Morphogenetic Protein-2: A Randomized Controlled Clinical Trial

Aim The purpose of this research was to assess the clinical and radiographic outcomes of recombinant human bone morphogenetic protein-2 (rhBMP-2) for the treatment of intraosseous abnormalities after periodontal flap surgery. Material and methods Patients aged 35-55 years who had undergone periodont...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Shashank, Kapoor, Radhika, Tyagi, Prashant, Wadhawan, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dentistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345880/
https://www.ncbi.nlm.nih.gov/pubmed/37456371
http://dx.doi.org/10.7759/cureus.40395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345880/
https://www.ncbi.nlm.nih.gov/pubmed/37456371
http://dx.doi.org/10.7759/cureus.40395

Ejemplares similares